583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians

Abstract Background Peru started its national vaccination campaign in February 2021 using Sinopharm vaccine, targeting healthcare personnel on its initial phase. Although the immunogenicity of this vaccine was tested in clinical trials, there are no studies that evaluated the humoral response post v...

Descripción completa

Detalles Bibliográficos

Autores principales:	María Victoria Lopera, Romina Vera, Carlos Tapia, Carlos Cabrera, Jose Armando Gonzales Zamora, Jorge Alave
Formato:	Artículo
Lenguaje:	inglés
Publicado:	2021
Materias:	Medicine Immunogenicity Vaccination Antibody Titer Cohort Neutralizing antibody Antibody titer Immunology Coronavirus disease 2019 (COVID-19) Internal medicine Virology Disease Infectious disease (medical specialty) Health Sciences Medicine Infectious Diseases SARS-CoV-2 and COVID-19 Research Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology vaccines and immunoinformatics approaches Health Sciences Medicine Infectious Diseases COVID-19 Clinical Research Studies
Acceso en línea:	Descargar el archivo Enlace permanente (DOI o Handle) Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!